Cognition Therapeutics (CGTX) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Cognition Therapeutics (CGTX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 6.12M | - | 3.77M (-67.16%) | 11M (+6.39%) | 11M (+32.39%) | 8.15M (-28.45%) | 11M (-1.64%) | 12M (+9.76%) | 11M (-9.05%) | 12M (-0.60%) | 12M (+37.29%) | 8.50M (+56.54%) | 5.43M (-15.68%) | 6.44M (-22.13%) | 8.27M (-9.12%) | 9.10M (+39.57%) | 6.52M (+17.06%) | 5.57M (+51.36%) | 3.68M (-24.74%) | 4.89M (+10.38%) | 4.43M (-53.32%) | 9.49M (+179.12%) | 3.40M | - | - |
Selling General And Administrative | 2.70M | - | 2.60M (+4.00%) | 2.50M (-16.39%) | 2.99M (+16.34%) | 2.57M (-16.29%) | 3.07M (-0.97%) | 3.10M (-12.68%) | 3.55M (-1.11%) | 3.59M (+16.56%) | 3.08M (-7.23%) | 3.32M (-6.21%) | 3.54M (+23.78%) | 2.86M (-34.40%) | 4.36M (+39.74%) | 3.12M (+7.59%) | 2.90M (-53.53%) | 6.24M (+302.58%) | 1.55M (+42.20%) | 1.09M (-5.22%) | 1.15M (-66.76%) | 3.46M (+226.42%) | 1.06M | - | - |
Operating Expenses | 8.82M | - | 6.38M (-54.36%) | 14M (+1.45%) | 14M (+28.54%) | 11M (-25.86%) | 14M (-1.50%) | 15M (+4.11%) | 14M (-7.18%) | 15M (+2.98%) | 15M (+24.79%) | 12M (+31.77%) | 8.97M (-3.55%) | 9.30M (-26.37%) | 13M (+3.44%) | 12M (+29.76%) | 9.41M (-20.32%) | 12M (+126.25%) | 5.22M (-12.71%) | 5.98M (+7.17%) | 5.58M (-56.91%) | 13M (+190.36%) | 4.46M | - | - |
Depreciation And Amortization | - | - | - | - | - | 80K | - | - | 30K (-62.50%) | 80K | - | - | 20K (-71.43%) | 70K | - | - | 20K (-71.43%) | 70K | - | - | 20K (-80.00%) | 100K | - | - | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -8.82M | - | -6.37M (-54.43%) | -13.98M (+1.53%) | -13.77M (+28.45%) | -10.72M (-25.86%) | -14.46M (-1.50%) | -14.68M (+4.11%) | -14.10M (-7.18%) | -15.19M (+3.05%) | -14.74M (+24.70%) | -11.82M (+31.77%) | -8.97M (-3.55%) | -9.30M (-26.31%) | -12.62M (+3.36%) | -12.21M (+29.76%) | -9.41M (-20.32%) | -11.81M (+126.25%) | -5.22M (-12.71%) | -5.98M (+7.17%) | -5.58M (-56.91%) | -12.95M (+190.36%) | -4.46M | - | - |
Ebit | -8.82M (-62.45%) | -23.49M (+268.76%) | -6.37M (-54.43%) | -13.98M (+1.53%) | -13.77M (+28.45%) | -10.72M (-25.86%) | -14.46M (-1.50%) | -14.68M (+4.11%) | -14.10M (-7.18%) | -15.19M (+3.05%) | -14.74M (+24.70%) | -11.82M (+31.77%) | -8.97M (-3.55%) | -9.30M (-26.31%) | -12.62M (+3.36%) | -12.21M (+29.76%) | -9.41M (-20.32%) | -11.81M (+126.25%) | -5.22M (-12.71%) | -5.98M (+7.17%) | -5.58M (-36.37%) | -8.77M (+96.64%) | -4.46M (+167.07%) | -1.67M (-33.47%) | -2.51M |
EBITDA | -4.57M (-80.54%) | -23.49M (+376.47%) | -4.93M (-26.75%) | -6.73M (-20.64%) | -8.48M (-62.82%) | -22.81M (+129.48%) | -9.94M (+41.19%) | -7.04M (-49.96%) | -14.07M (-53.41%) | -30.20M (+347.41%) | -6.75M (+42.71%) | -4.73M (-47.15%) | -8.95M (-58.51%) | -21.57M (+225.83%) | -6.62M (+12.59%) | -5.88M (-37.38%) | -9.39M (-48.80%) | -18.34M (+489.71%) | -3.11M (+108.72%) | -1.49M (-73.20%) | -5.56M (-53.08%) | -11.85M (+825.78%) | -1.28M (-23.35%) | -1.67M (-33.47%) | -2.51M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 900K | - | - | - | 1.25M (+145.10%) | 510K | - | - |
Other Non Operating Income | 4.25M | - | 1.45M (-79.97%) | 7.24M (+36.60%) | 5.30M (-73.50%) | 20M (+341.50%) | 4.53M (-40.71%) | 7.64M (+54.34%) | 4.95M (-80.15%) | 25M (+211.75%) | 8.00M (+12.83%) | 7.09M (+153.21%) | 2.80M (-87.36%) | 22M (+269.17%) | 6.00M (-5.36%) | 6.34M (+11.23%) | 5.70M (-66.23%) | 17M (+700.00%) | 2.11M (-53.01%) | 4.49M (-22.72%) | 5.81M (-39.29%) | 9.57M (+258.43%) | 2.67M | - | - |
Net Income | |||||||||||||||||||||||||
Income Before Tax | - | - | - | - | - | - | - | - | - | 11M | - | -4.73M (-23.34%) | -6.17M | 9.59M | - | -5.88M (+58.49%) | -3.71M | 1.27M | - | -1.49M | 220K | - | - | - | - |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -120.00K | 130K | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -4.57M (-80.54%) | -23.49M (+376.47%) | -4.93M (-26.75%) | -6.73M (-20.64%) | -8.48M (+8.16%) | -7.84M (-21.13%) | -9.94M (+41.19%) | -7.04M (-23.06%) | -9.15M (+12.41%) | -8.14M (+20.59%) | -6.75M (+42.71%) | -4.73M (-23.34%) | -6.17M (+19.11%) | -5.18M (-21.75%) | -6.62M (+15.13%) | -5.75M (+49.74%) | -3.84M (-47.68%) | -7.34M (+136.01%) | -3.11M (+108.72%) | -1.49M | 220K | -1.87M (+4.47%) | -1.79M (+7.19%) | -1.67M (-33.47%) | -2.51M |
Net Income | -4.57M (-80.54%) | -23.49M (+376.47%) | -4.93M (-26.75%) | -6.73M (-20.64%) | -8.48M (+8.16%) | -7.84M (-21.13%) | -9.94M (+41.19%) | -7.04M (-23.06%) | -9.15M (+12.41%) | -8.14M (+20.59%) | -6.75M (+42.71%) | -4.73M (-23.34%) | -6.17M (+19.11%) | -5.18M (-21.75%) | -6.62M (+15.13%) | -5.75M (+49.74%) | -3.84M (-47.68%) | -7.34M (+136.01%) | -3.11M (+108.72%) | -1.49M | 220K | -1.87M (+4.47%) | -1.79M (+7.19%) | -1.67M (-33.47%) | -2.51M |
Comprehensive Income Net Of Tax | -4.57M | - | -4.93M (-26.75%) | -6.73M (-20.64%) | -8.48M (-74.90%) | -33.78M (+239.84%) | -9.94M (+41.19%) | -7.04M (-21.43%) | -8.96M (-65.24%) | -25.78M (+281.93%) | -6.75M (+42.71%) | -4.73M (-23.34%) | -6.17M (-71.17%) | -21.40M (+222.78%) | -6.63M (+15.30%) | -5.75M (+49.74%) | -3.84M (-67.26%) | -11.73M (+277.17%) | -3.11M (+108.72%) | -1.49M | 220K | -7.84M (+342.94%) | -1.77M | - | - |